Percutaneous closure of a secundum atrial septal defect and double balloon valvotomies of a severe mitral and aortic valve stenosis in a patient with Lutembacher's syndrome and severe pulmonary hypertension.

This is a 43-yr-old female presenting with recurrent atrial septal defect, closed surgically, 10 years prior, severe aortic and mitral stenosis, and severe tricuspid regurgitation. She was considered inoperable because of the severe pulmonary hypertension and the complexity of the disease. A percutaneous umbrella closure of the atrial septal defect in conjunction with mitral and aortic balloon valvotomies could be safely and successfully performed. After significant clinical and hemodynamic improvement, surgery was judged feasible, but was refused by the patient who suddenly expired 8 weeks later. The usefulness of percutaneous therapy as a rescue procedure and the management of patients with Eisenmenger's physiology are discussed.
AuthorsC E Ruiz, H Gamra, P Mahrer, J W Allen, M P O'Laughlin, F Y Lau
JournalCatheterization and cardiovascular diagnosis (Cathet Cardiovasc Diagn) Vol. 25 Issue 4 Pg. 309-12 (Apr 1992) ISSN: 0098-6569 [Print] UNITED STATES
PMID1373992 (Publication Type: Case Reports, Journal Article)
  • Adult
  • Aortic Valve Stenosis (radiography, therapy)
  • Cardiac Catheterization (instrumentation)
  • Catheterization (instrumentation)
  • Female
  • Heart Septal Defects, Atrial (radiography, therapy)
  • Hemodynamics (physiology)
  • Humans
  • Hypertension, Pulmonary (radiography, therapy)
  • Lutembacher Syndrome (radiography, therapy)
  • Mitral Valve Stenosis (radiography, therapy)
  • Palliative Care
  • Recurrence
  • Rheumatic Heart Disease (radiography, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: